# Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria

> **NCT00486694** · PHASE2 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 190 (actual)

## Conditions studied

- Malaria, Vivax

## Interventions

- **DRUG:** Sulfadoxine-pyrimethamine + artesunate
- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT00486694
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2007-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486694, "Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00486694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*